Review
Published on 16 Oct 2023
SET-CAN/NUP214 fusion gene in leukemia: general features and clinical advances
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1269531
- 2,529 views
Type at least 3 characters
1,747 articles
Articles
Original Research
Published on 16 Oct 2023
TP53 Gene 72 Arg/Pro (rs1042522) single nucleotide polymorphism increases the risk and the severity of chronic lymphocytic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1272876
- 2,052 views
- 6 citations
Brief Research Report
Published on 13 Oct 2023
The outcome of acute leukemia patients with SET-NUP214 fusion after allogeneic stem cell transplantation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1256043
- 1,392 views
- 1 citation
Review
Published on 13 Oct 2023
Germline and somatic drivers in inherited hematologic malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1205855
- 2,518 views
Systematic Review
Published on 06 Oct 2023
Prevalence and effect on survival of pre-treatment sarcopenia in patients with hematological malignancies: a meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1249353
- 1,740 views
- 2 citations
Brief Research Report
Published on 06 Oct 2023
Germline landscape of RPA1, RPA2 and RPA3 variants in pediatric malignancies: identification of RPA1 as a novel cancer predisposition candidate gene
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1229507
- 2,426 views
Review
Published on 04 Oct 2023
Location, location, location: mapping the lymphoma tumor microenvironment using spatial transcriptomics
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1258245
- 4,489 views
- 1 citation
Correction
Published on 04 Oct 2023
Corrigendum: Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1302993
- 626 views
Mini Review
Published on 04 Oct 2023
Challenges associated with the identification of germline variants on myeloid malignancy genomic profiling—a Singaporean experience
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1182639
- 1,762 views
- 1 citation
Editorial
Published on 04 Oct 2023
Editorial: Biological aspects of bone marrow failure
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1295823
- 947 views
Original Research
Published on 03 Oct 2023
Microenvironmental immune cell alterations across the spectrum of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1267604
- 2,070 views
- 2 citations
Original Research
Published on 03 Oct 2023
Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar era
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1248723
- 1,982 views
- 1 citation
Mini Review
Published on 02 Oct 2023
The interplay of FLT3 and CXCR4 in acute myeloid leukemia: an ongoing debate
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1258679
- 1,970 views
- 1 citation
Review
Published on 02 Oct 2023
Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profiling
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1240966
- 3,898 views
- 5 citations
Case Report
Published on 02 Oct 2023
Case Report: A recurrent case of ALK-ALCL after autologous transplantation was successfully treated with BV + a modified CHEP chemotherapy containing mitoxantrone hydrochloride liposome with the addition of chidamide maintenance therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1242552
- 1,708 views
Case Report
Published on 29 Sep 2023
Leukemic conversion involving RAS mutations of type 1 CALR-mutated primary myelofibrosis in a patient treated for HCV cirrhosis: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1266996
- 2,082 views
- 2 citations